Medindia
Medindia LOGIN REGISTER
Advertisement

PharmaVentures Appoints Paul Phull as Senior Director

Tuesday, August 31, 2010 Drug News
Advertisement
OXFORD, England, August 31, 2010

- New Business Development Expert Brings More Than 20 Years of IndustryM&A and Licensing Experience to Strengthen Pharmaventures' Corporate AdvisoryServices to its Clients
Advertisement

PharmaVentures Ltd (http://www.pharmaventures.com) ("PharmaVentures")today announced that Paul Phull has joined the company as Senior Director.With more than 24 years of senior level commercial, business/corporatedevelopment and general management experience in the pharmaceutical,biotechnology and medical device industries, Paul will be responsible fordeveloping PharmaVentures' Corporate Advisory business.
Advertisement

Paul joins PharmaVentures from Sinclair Pharma plc, a UK listed specialtypharmaceutical company, where he was responsible for the development of theinternational business with a marketing partner network spanning over 80countries. He was also responsible for corporate development and worked onthe acquisition and integration of European sales and marketing companies inFrance, Spain and Italy into the Sinclair group. Paul has significant dealmaking and corporate transaction experience with a broad range and size ofcompanies in Europe, USA, Japan, India and Asia in a number of therapeuticareas.

"I am very pleased to welcome Paul to PharmaVentures," said Dr FintanWalton, Chief Executive Officer. "His strategic approach and industryexperience will significantly enhance corporate advisory services,particularly with respect to our transactions offerings."

About PharmaVentures

PharmaVentures Limited (http://www.pharmaventures.com) is based inOxford, England and is a leading international corporate advisory firmsupporting its clients' growth ambitions through licensing, joint venturesand M&A in the healthcare industry. The company works for a variety ofclients from start-ups to global pharmaceutical corporations, their advisors,investment companies and government bodies. It also produces the highlypopular PharmaDeals(R) range of intelligence products including analysistools and reports. In 2006 it launched the world's first dedicated onlinepharmaceutical television channel PharmaTelevision(R) (http://www.pharmatelevision.com)Doug Cookson Commercial Director, PharmaVentures T: +44(0)1865-332731 E: [email protected]

SOURCE PharmaVentures
Sponsored Post and Backlink Submission


Latest Press Release on Drug News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close